Topics

Leerink Transformation Partners Company Profile

08:02 EDT 18th September 2019 | BioPortfolio


News Articles [615 Associated News Articles listed on BioPortfolio]

BHE Raises $78M To Expand Real-World Evidence Analytics Platform

BHE, a Boston, MA-based innovative healthcare analytics company, today announced a $78 million minority growth investment led by Silversmith Capital Partners (“Silversmith”) and Leerink Transforma...

Equillium to Present at Leerink Partners Global Healthcare Conference

LA JOLLA, Calif., Feb. 21, 2019 (GLOBE NEWSWIRE) -- Equillium, Inc. (Nasdaq: EQ), a biotechnology company developing treatments for severe immune-inflammatory disorders, announced today that Bruce ...

AMAG Pharmaceuticals to Present at Leerink Partners Global Healthcare Conference

WALTHAM, Mass., Feb. 19, 2019 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) will present at the Leerink Partners Global Healthcare Conference on Wednesday, February 27, 2019. Ted Myl...

Iterum to Present at the 8th Annual SVB Leerink Partners Global Healthcare Conference

DUBLIN, Ireland and CHICAGO, Feb. 19, 2019 (GLOBE NEWSWIRE) -- Iterum Therapeutics plc (Nasdaq: ITRM), a clinical-stage pharmaceutical company developing antibiotics against multi-drug resistant pa...

CureVac to Present at the 8th Annual Leerink Partners Global Healthcare Conference

TÜBINGEN, Germany and BOSTON, Feb. 19, 2019 (GLOBE NEWSWIRE) -- CureVac AG, a fully integrated biopharmaceutical company pioneering the field of mRNA-based drugs, today announced that Dan Menichel...

scPharmaceuticals Inc. to Present at the 8th Annual SVB Leerink Partners Global Healthcare Conference

BURLINGTON, Mass., Feb. 21, 2019 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to op...

Translate Bio to Present at the 8th Annual SVB Leerink Partners Global Healthcare Conference

LEXINGTON, Mass., Feb. 14, 2019 (GLOBE NEWSWIRE) -- Translate Bio (Nasdaq: TBIO), a clinical-stage messenger RNA (mRNA) therapeutics company developing a new class of potentially transformative med...

Gritstone Oncology to Present at Leerink Partners Annual Global Healthcare Conference

EMERYVILLE, Calif., Feb. 20, 2019 (GLOBE NEWSWIRE) -- Gritstone Oncology (Nasdaq: GRTS), a clinical-stage biotechnology company developing the next generation of cancer immunotherapies to fight mul...

Drugs and Medications [94 Associated Drugs and Medications listed on BioPortfolio]

Oxygen [respiratory care partners, inc]

Oxygen

Moderiba [abbvie inc.]

These highlights do not include all the information needed to use Moderiba (ribavirin, USP) safely and effectively. See full prescribing information for Moderiba (ribavirin, USP). Moderiba (ribavirin,...

Ribavirin [sandoz inc]

These highlights do not include all the information needed to use RIBAVIRIN TABLETS safely and effectively. See full prescribing information for RIBAVIRIN TABLETS. RIBAVIRIN tablets, for oral useIniti...

Ribavirin [richmond pharmaceuticals, inc.]

These highlights do not include all the information needed to use ribavirin tablets safely and effectively. See full prescribing information for ribavirin tablets. Ribavirin Tablets for oral useInitia...

Ribavirin [aurobindo pharma limited]

These highlights do not include all the information needed to use RIBAVIRIN TABLETS safely and effectively. See full prescribing information for RIBAVIRIN TABLETS. RIBAVIRIN tablets, for oral use Init...

PubMed Articles [695 Associated PubMed Articles listed on BioPortfolio]

Adolescents' Contraceptive Use with School-Discordant Partners: Exploring Individual- and Relationship-Level Characteristics.

Heterosexual adolescents are less likely to use contraceptives when their partners are of different backgrounds or social circles. It is unclear why risky behaviors are more common within these relati...

Psychological interventions targeting partners of cancer patients: A systematic review.

Cancer patients' intimate partners often experience levels of psychological burden that are comparable to or even exceed that of the patients, making it imperative that they too be provided with appro...

Transformation of roxarsone during UV disinfection in the presence of ferric ions.

The transformation of roxarsone (ROX) during UV disinfection with Fe(III) has been investigated. Fe(OH), as the main Fe(III) species at pH = 3, produces HO under UV irradiation leading to the oxid...

Relationship Satisfaction of Intimate Partners of Persons Living With Urinary Incontinence.

The purpose of this study was to examine effects of urinary incontinence (UI) on midlife women's relationships with their intimate partners, from the perspective of both women and their partners.

Taking active steps: Changes made by partners of people with multiple sclerosis who undertake lifestyle modification.

Multiple sclerosis (MS), a demyelinating condition of the central nervous system with an unpredictable course, has a major impact on the lives of people with MS. Partners of people with MS may be sign...

Clinical Trials [541 Associated Clinical Trials listed on BioPortfolio]

The Influence of GVS on Mental Transformation

Corroboratory behavioral evidence showed interaction effects between vestibular stimulation and egocentric transformation. The investigators here examine in healthy participants, whether ...

ObinutuzuMab AtezOlizumab and VenetocLax in RichTer transfOrmation

This study is a multicenter, open-label, uncontrolled, phase II trial aimed to establish the safety and tolerability of venetoclax, atezolizumab and obinutuzumab combination in Richter Tra...

Predictive Value of Infarction Volume on Hemorrhagic Transformation in Ischemic Stroke/TIA With Non-valve Atrial Fibrillation(NVAF) Patients Using Rivaroxaban

This study was aimed at patients with newly diagnosed stroke / TIA associated with nonvalvular atrial fibrillation. We will observe the effect of early using rivaroxaban anticoagulation on...

Partners Demonstration Project of PrEP and ART

The purpose of this protocol is to determine user preferences for antiretroviral therapy (ART) for HIV-1 infected partners and pre-exposure prophylaxis (PrEP) HIV-1 un-infected partners an...

Risk Assessment and Syndrome Evolution Models for Chronic Atrophic Gastritis Malignant Transformation

Chronic atrophic gastritis (CAG) is acknowledged as the precancerous stage of gastric cancer (GC). The present study aims to developed risk assessment and syndrome evolution models of CAG ...

Companies [1112 Associated Companies listed on BioPortfolio]

Leerink Partners LLC

Leerink Partners LLC is a leading investment bank, specializing in healthcare. Our knowledge, experience and focus enable us to help our clients define and achieve their strategic...

Leerink Transformation Partners

Leerink Swann

Leerink Swann is a healthcare-focused investment banking firm that provides equity research, corporate finance, strategic advisory and asset management services for institutional,...

Leerink Capital Partners

Capgemini Consulting

Capgemini Consulting is the global strategy and transformation consulting organization of the Capgemini Group, specializing in advising and supporting enterprises in significant t...

More Information about "Leerink Transformation Partners" on BioPortfolio

We have published hundreds of Leerink Transformation Partners news stories on BioPortfolio along with dozens of Leerink Transformation Partners Clinical Trials and PubMed Articles about Leerink Transformation Partners for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Leerink Transformation Partners Companies in our database. You can also find out about relevant Leerink Transformation Partners Drugs and Medications on this site too.

Quick Search

Corporate Database Quicklinks



Searches Linking to this Company Record